Breaking News Instant updates and real-time market news.

AAPL

Apple

$148.98

-6.01 (-3.88%)

, MSFT

Microsoft

$70.32

-1.63 (-2.27%)

06:20
06/12/17
06/12
06:20
06/12/17
06:20

Tech CEOs to attend first American Technology Council summit, Bloomberg reports

Apple (AAPL) CEO Tim Cook, Microsoft (MSFT) CEO Satya Nadella and Amazon (AMZN) CEO Jeff Bezos along with several other tech executives will visit White House on June 19 for first meeting of The American Technology Council, led by Jared Kushner, President Trump's son-in-law and senior adviser, Bloomberg reports, citing three people familiar with the plans. Others expected to attend the summit include Oracle (ORCL) Co-CEO Safra Catz, IBM (IBM) CEO Ginni Rometty and Alphabet (GOOG, GOOGL) executive chairman Eric Schmidt. Reference Link

AAPL

Apple

$148.98

-6.01 (-3.88%)

MSFT

Microsoft

$70.32

-1.63 (-2.27%)

AMZN

Amazon.com

$978.31

-31.96 (-3.16%)

ORCL

Oracle

$45.03

-0.39 (-0.86%)

IBM

IBM

$154.10

2 (1.31%)

GOOG

Alphabet

$949.83

-33.58 (-3.41%)

GOOGL

Alphabet Class A

$970.12

-34.16 (-3.40%)

  • 20

    Jun

  • 21

    Jun

  • 28

    Jun

  • 19

    Jul

AAPL Apple
$148.98

-6.01 (-3.88%)

06/07/17
ARGS
06/07/17
NO CHANGE
ARGS
Apple price target raised to $175 from $160 at Argus
Argus analyst Jim Kelleher increased his price target on Apple after the company annoucned new products and product enhancements. The analyst quotes Apple bears as saying that the company is "playing catch-up" by introducing similar products to those that its rivals have already launched. However, Kelleher says that, "coming late to the party did not hurt iPhone's leadership in smartphones." He keeps a Buy rating on the shares. .
06/07/17
RBCM
06/07/17
NO CHANGE
RBCM
Analog Devices weakness will be short lived, says RBC Capital
RBC Capital analyst Amit Daryanani notes that Analog Devices (ADI) "has underperformed rather notably" since its Q2 results on May 31. The analyst blames the weakness on the company's reduced revenue from Apple (AAPL). However, he thinks that investors will begin focusing more on the company's multiple tailwinds, possibly starting in the wake of its June 20 Analyst Day. Consequently, he expects the stock to rise from current levels and keeps a $92 price target and Outperform rating on the shares.
06/06/17
COWN
06/06/17
NO CHANGE
Target $60
COWN
Outperform
Criteo stock reaction after Apple developer conference overdone, says Cowen
Cowen analyst Thomas Champion noted Criteo (CRTO) shares were under pressure following comments from the Apple (AAPL) developer conference yesterday, but he believes exposure to the desktop Safari browser seems limited, which will mitigate risk to revenue, suggesting the stock reaction is overdone. Champion reiterated his Outperform rating on Criteo shares.
06/11/17
MZHO
06/11/17
DOWNGRADE
Target $150
MZHO
Neutral
Apple downgraded to Neutral from Buy at Mizuho
Mizuho analyst Abhey Lamba downgraded Apple to Neutral from Buy and lowered his price target for the shares to $150 from $160. The iPhone maker fell along with the Nasdaq index late in Friday's trade to close down 4%, or $6.01, to $148.98. "Enthusiasm" around the upcoming iPhone launch is fully priced in after the stock's year-to-date outperformance, Lamba wrote to investors Sunday night. The analyst sees limited upside to consensus estimates and notes Apple shares are trading near the upper-end of their recent valuation range.
MSFT Microsoft
$70.32

-1.63 (-2.27%)

05/11/17
BMOC
05/11/17
NO CHANGE
BMOC
Microsoft statements positive, says BMO Capital
After attending Microsoft's Analyst Day, BMO Capital analyst Keith Bachman says that Microsoft's " tone and confidence on competencies, culture, products, and opportunities were very bullish." The analyst says that some of the company's comments indicate that its fiscal 2018 results could miss expectations, but he's more upbeat on the company's longer term outlook and thinks that its operating income will increase around 5% in fiscal 2018, enabling the stock's multiple to rise. He keeps a $75 price target and Outperform rating on the shares.
05/15/17
BERN
05/15/17
NO CHANGE
BERN
Microsoft poised to benefit from cybersecurity developments, says Bernstein
Bernstein analyst Pierre Ferragu expects the WannaCry cyber attack to cause more companies to upgrade to newer versions of Microsoft's operating system, thereby benefiting the company. The analyst adds that the company could benefit from the federal government's inxreased usage of the cloud in the wake of President Trump's executive order on cybersecurity.
05/25/17
RBCM
05/25/17
NO CHANGE
RBCM
Microsoft named a favorite large cap software idea at RBC Capital
RBC Capital analyst MAtthew Hedberg named Microsoft one of his favorite large cap software ideas. The analyst expects the company to benefit from strong sales of its Azure and Office 365 products, as well as more efficient spending and increased commercial cloud margins.
05/23/17
MAXM
05/23/17
NO CHANGE
Target $41
MAXM
Buy
Nutanix pact with IBM potentially more powerful than Dell deal, says Maxim
Maxim analyst Nehal Chokshi said he views Nutanix' (NTNX) announcement of a multi-year initiative that will combine IBM's (IBM) P-series servers and Nutanix' Enterprise Cloud Platform as a "very significant mid-term positive." He believes the partnership gives IBM a powerful infrastructure software answer to VMware (VMW) and Microsoft (MSFT) and sees the relationship with the potential to be even more powerful than the Dell relationship that powered Nutanix' improving FY16 sales productivity and cash flow. Chokshi keeps a Buy rating on Nutanix but trimmed his price target to $41 from $42 to account for Dell siphoning Nutanix leads to VMware, as previously discussed.
AMZN Amazon.com
$978.31

-31.96 (-3.16%)

06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).
06/07/17
MSCN
06/07/17
NO CHANGE
MSCN
Amazon.com Q2 revenues tracking below consensus, says MScience
06/06/17
MAXM
06/06/17
NO CHANGE
Target $1300
MAXM
Buy
Maxim sees ten $1T categories open to Amazon, ups target to $1,300
Maxim analyst Tom Forte said that as consumers increasingly interact with Amazon in physical locations, "Amazon.com will become simply Amazon." Forte analyzed 18 market opportunities, including 14 that Amazon is already pursuing and four - credit, gas stations, pharmacy, and travel - that are new, and among them identified ten categories where the global total addressable market exceeds $1T. Given Amazon's opportunity to drive incremental sales growth and "further disrupt the retail sector," Forte raised his price target on the stock to $1,300 from $1,075 and keeps a Buy rating on the name.
06/12/17
PIPR
06/12/17
NO CHANGE
Target $1200
PIPR
Overweight
Amazon.com price target raised to $1,200 from $1,050 at Piper Jaffray
Piper Jaffray analyst Michael Olson continues to believe that Amazon.com is the best positioned large cap internet platform for the next five-plus years. He raised his price target for the shares to $1,200 from $1,050 and reiterates an Overweight rating on the name. The stock closed Friday down $31.96, or 3%, to $978.31. An analysis of Google search trends indicates Amazon retail unit growth will likely see little to no deceleration in Q2 relative to the 24% growth experienced in Q1, Olson tells investors in a research note. He believes Amazon retail is tracking for an in-line quarter. The analyst reiterates an Overweight rating on the shares.
ORCL Oracle
$45.03

-0.39 (-0.86%)

04/27/17
BNCH
04/27/17
INITIATION
Target $55
BNCH
Buy
Oracle initiated with a Buy at Benchmark
Benchmark analyst Yun Kim initiated Oracle with a Buy rating and $55 price target.
05/11/17
SOCG
05/11/17
DOWNGRADE
SOCG
Hold
Oracle downgraded to Hold from Buy at Societe Generale
05/15/17
BNCH
05/15/17
NO CHANGE
Target $110
BNCH
Buy
Salesforce price target raised to $110 ahead of earnings at Benchmark
Benchmark analyst Yun Kim said his checks indicate that Salesforce (CRM) is beginning to replace SAP (SAP) and Oracle (ORCL) as the "de facto standard" in enterprise business applications and he expects Salesforce to report at least in-line Q1 results and give at least in-line Q2 guidance. Ahead of the company's upcoming Q1 report, which is due on May 18, Kim raised his price target on Salesforce shares to $110 from $100 and keeps a Buy rating on the stock.
06/08/17
OTRG
06/08/17
UPGRADE
OTRG
Positive
Oracle upgraded to Positive from Mixed at OTR Global
OTR Global upgraded Oracle to Positive following partner checks that generally reported solid year-end business activity.
IBM IBM
$154.10

2 (1.31%)

05/19/17
05/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Bernstein initiated Nvidia (NVDA) with an Outperform and a $165 price target. 2. Cantor Fitzgerald initiated Thermo Fisher (TMO) with an Overweight rating and $194 price target. 3. Pacific Crest initiated IBM (IBM) with a Sector Weight rating. 4. Conduent (CNDT) initiated with a Market Perform rating and $18 price target at Cowen. 5. JMP Securities started coverage of Spring Bank Pharmaceuticals (SBPH) with a $20 price target and an Outperform rating. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/17
PACS
05/18/17
INITIATION
PACS
Sector Weight
IBM initiated with a Sector Weight at Pacific Crest
06/08/17
STFL
06/08/17
NO CHANGE
STFL
IBM defended after CNBC report at Stifel
After CNBC reported that Facebook's (FB) WhatsApp had decided to stop using IBM's (IBM) cloud service and build its own solution, Stifel analyst David Grossman says that WhatsApp accounted for a tiny portion of IBM's cloud/outsourcing revenue. The analyst reiterated that bookings disclosed by IBM so far this quarter increase his confidence that its Infrastructure Services business "can stabilize in 2H17, all else being equal." He notes that the business accounts for about 30% of the company's revenue. Devitt keeps a $182 price target and Buy rating on the stock.
GOOG Alphabet
$949.83

-33.58 (-3.41%)

06/09/17
06/09/17
NO CHANGE

Nvidia seen trading 'back to $130' by Citron Research
Citron Research, which has previously been cautious on Nvidia (NVDA), recommends that investors take profits and invest instead in Alphabet (GOOG), which it sees having "exposure to the identical array of 'sexy businesses' with less risk on the downside." Reference Link
05/23/17
MSCO
05/23/17
NO CHANGE
Target $305
MSCO
Equal Weight
Alphabet's Waymo an emerging competitor to Tesla, says Morgan Stanley
After Morgan Stanley's Internet team, led by analyst Brian Nowak, said they view the partnership that Waymo, Alphabet's (GOOG) autonomous driving unit, has struck with Lyft as an important step in the "Other Bet" company's ability to help drive the autonomous transition, analyst Adam Jonas said the Waymo/Lyft partnership is an emerging competitor to Tesla (TSLA) in autonomous mobility. Jonas keeps an Equal Weight rating and $305 price target on Tesla shares.
05/31/17
MSCO
05/31/17
NO CHANGE
Target $305
MSCO
Equal Weight
Tesla seen more widely as 'more than a car company,' says Morgan Stanley
Morgan Stanley analyst Adam Jonas said he believes the market is increasingly viewing Tesla (TSLA) as "more than a car company," giving it a low chance of success of disrupting a $10T global market for mobility rather than a high chance of success in the smaller traditional light vehicle market. There is "little doubt that Tesla has a seat at the table" for any conversation about machine learning and the multi-trillion-dollar transport market alongside Amazon (AMZN), Alphabet (GOOG), and Apple (AAPL), though its market cap is only a fraction of theirs, Jonas tells investors. The analyst, who added that the firm is getting a "surprisingly high level of pushback" on its prior work on Google's self-driving Waymo unit - with some saying they undervalued Waymo and others saying they undervalued Tesla's shared/autonomous mobility efforts - keeps an Equal Weight rating and $305 price target on Tesla shares.
06/06/17
JPMS
06/06/17
NO CHANGE
JPMS
Overweight
Criteo selloff on Apple iOS update overdone, says JPMorgan
Criteo (CRTO) dropped 7% yesterday after Apple (AAPL) announced that it will limit ad tracking on desktop browsers with the iOS 11 update, JPMorgan Doug Anmuth tells investors in a research note. The news follows Google's (GOOG, GOOGL) recent announcement that Chrome will stop showing ads on sites that do not meet its ad criteria beginning in 2018, the analyst adds. Anmuth does not expect much financial impact to Criteo from either change in the near term. He believes both Apple and Google will ultimately leave ads up to the end user to manage. The analyst views yesterday's selloff in Criteo shares as overdone and keeps an Overweight rating on the name.
GOOGL Alphabet Class A
$970.12

-34.16 (-3.40%)

TODAY'S FREE FLY STORIES

SM

SM Energy

$13.47

-0.0792 (-0.58%)

11:00
08/22/17
08/22
11:00
08/22/17
11:00
Options
Opening buyer snaps up SM Energy downside 12.5 puts »

Opening buyer snaps up SM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

YPF

YPF

$20.14

0.28 (1.41%)

10:55
08/22/17
08/22
10:55
08/22/17
10:55
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$30.54

-0.29 (-0.94%)

10:52
08/22/17
08/22
10:52
08/22/17
10:52
Conference/Events
Columbus McKinnon management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

  • 29

    Nov

  • 30

    Nov

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

, BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

10:44
08/22/17
08/22
10:44
08/22/17
10:44
Hot Stocks
S&P removes Berkshire Hathaway from CreditWatch, calls outlook 'stable' »

S&P Global Ratings…

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$23.78

0.4 (1.71%)

10:40
08/22/17
08/22
10:40
08/22/17
10:40
Options
Bank of America calls active as shares see strength »

Bank of America calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
08/22/17
08/22
10:40
08/22/17
10:40
General news
Treasury Option Action: a build-up of bullish call butterflies »

Treasury Option Action: a…

WILC

G. Willi-Food

$6.49

-0.0209 (-0.32%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Hot Stocks
G. Willi-Food names Zwi Williger as co-chairman »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$8.37

-0.18 (-2.11%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/22/17
08/22
10:35
08/22/17
10:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Recommendations
Medtronic, Dexcom, TNDM analyst commentary  »

Medtronic challenges in…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

TWX

Time Warner

$101.67

-0.44 (-0.43%)

, T

AT&T

$37.63

0.045 (0.12%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Periodicals
Time Warner-AT&T deal questioned by Brazil regulator, Bloomberg says »

Brazils antitrust…

TWX

Time Warner

$101.67

-0.44 (-0.43%)

T

AT&T

$37.63

0.045 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FCX

Freeport McMoRan

$15.37

0.6399 (4.34%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Technical Analysis
Technical View: Freeport McMoRan breaks through top of recent range »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$18.92

3.23 (20.59%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Downgrade
DSW rating change  »

DSW downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RDFN

Redfin

$27.56

0.86 (3.22%)

, EGN

Energen

$50.21

0.65 (1.31%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on the…click here.

RDFN

Redfin

$27.56

0.86 (3.22%)

EGN

Energen

$50.21

0.65 (1.31%)

PXD

Pioneer Natural

$128.63

0.69 (0.54%)

RVNC

Revance

$22.70

-0.45 (-1.94%)

PCRX

Pacira

$35.75

-0.05 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

  • 25

    Sep

  • 02

    Nov

MYL

Mylan

$30.44

-0.28 (-0.91%)

, BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MYL

Mylan

$30.44

-0.28 (-0.91%)

BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

GMRE

Global Medical REIT

$8.38

-0.6 (-6.68%)

NXTM

NxStage Medical

$29.11

-0.14 (-0.48%)

FMS

Fresenius Medical

$46.69

0.37 (0.80%)

HKMPY

Hikma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 03

    Sep

  • 06

    Sep

  • 08

    Sep

  • 15

    Sep

  • 09

    Oct

BABA

Alibaba

$171.47

2.22 (1.31%)

, VMW

VMware

$98.97

1.96 (2.02%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

BABA

Alibaba

$171.47

2.22 (1.31%)

VMW

VMware

$98.97

1.96 (2.02%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

EL

Estee Lauder

$106.53

0.05 (0.05%)

TPX

Tempur Sealy

$62.42

0.91 (1.48%)

WUBA

58.com

$63.80

-0.34 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

FEYE

FireEye

$13.77

-0.21 (-1.50%)

10:25
08/22/17
08/22
10:25
08/22/17
10:25
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

VMW

VMware

$99.09

2.08 (2.14%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:23
08/22/17
08/22
10:23
08/22/17
10:23
Hot Stocks
Deutsche ups VMware on slower than expected enterprise move to public cloud »

Deutsche Bank upgraded…

VMW

VMware

$99.09

2.08 (2.14%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

ORCL

Oracle

$49.11

0.205 (0.42%)

RHT

Red Hat

$102.19

-0.465 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

  • 05

    Sep

TWX

Time Warner

$101.80

-0.31 (-0.30%)

, T

AT&T

$37.77

0.1899 (0.51%)

10:21
08/22/17
08/22
10:21
08/22/17
10:21
Periodicals
Time Warner, AT&T deal questioned by Brazil antitrust agency, Bloomberg says »

Shares of Time Warner…

TWX

Time Warner

$101.80

-0.31 (-0.30%)

T

AT&T

$37.77

0.1899 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SHLD

Sears

$8.55

-0.1 (-1.16%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:19
08/22/17
08/22
10:19
08/22/17
10:19
Hot Stocks
Sears jumps after announcing latest licensing deals for Kenmore, DieHard brands »

Shares of Sears Holdings…

SHLD

Sears

$8.55

-0.1 (-1.16%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

LOW

Lowe's

$75.27

1.42 (1.92%)

HD

Home Depot

$150.33

1.13 (0.76%)

BBY

Best Buy

$61.37

0.9185 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 29

    Aug

  • 19

    Sep

  • 21

    Nov

$NSD

NASDAQ Market Internals

10:17
08/22/17
08/22
10:17
08/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PULM

Pulmatrix

$1.67

-0.03 (-1.76%)

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Hot Stocks
Pulmatrix patent for respirable tiotropium dry powders posted to USPTO site 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/22/17
08/22
10:15
08/22/17
10:15
General news
U.S. Richmond Fed manufacturing index was flat at 14 in August »

U.S. Richmond Fed…

AVGO

Broadcom

$249.62

0.25 (0.10%)

10:10
08/22/17
08/22
10:10
08/22/17
10:10
Options
Bullish option play in Broadcom ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.